Alexandra M. Easson
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Alexandra M. Easson has a total of 217 co-authors. Here are the top co-authors by number of shared publications:
David R. McCready
22 shared publicationsMichael Reedijk
22 shared publicationsAyman Al-Habeeb
20 shared publicationsLinh T. Nguyen
20 shared publications- Pamela S. Ohashi
Department of Immunology, University of Toronto, Toronto, ON M5S 1A8, Canada
20 shared publications Aras Toker
19 shared publications
Latest Publications
- Open Access
- 31 March 2023
- Published by American Association for Cancer Research (AACR)
Figure S1 from Regulatory T Cells in Ovarian Cancer Are Characterized by a Highly Activated Phenotype Distinct from that in Melanoma
Flow cytometry analysis of intratumoral Treg cells
- 31 March 2023
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S1 from Regulatory T Cells in Ovarian Cancer Are Characterized by a Highly Activated Phenotype Distinct from that in Melanoma
Flow cytometry analysis of intratumoral Treg cells
- Open Access
- 31 March 2023
- Published by American Association for Cancer Research (AACR)
Supplemental Tables from Regulatory T Cells in Ovarian Cancer Are Characterized by a Highly Activated Phenotype Distinct from that in Melanoma
Supplemental Table 1: Patient clinical and specimen information. NOS, not otherwise specified; FC, flow cytometry; FA, functional assay; Bisu, bisulfilte sequencing Supplemental Table 2: Genes differentially expressed in intratumoral PD-1intICOS-hi cells, compared to PD-1hiICOSint and PD 1-ICOS-. Supplemental Table 3: Markers and antibodies used for mass cytometry.
- 31 March 2023
- Published by American Association for Cancer Research (AACR)
Open AccessSupplemental Tables from Regulatory T Cells in Ovarian Cancer Are Characterized by a Highly Activated Phenotype Distinct from that in Melanoma
Supplemental Table 1: Patient clinical and specimen information. NOS, not otherwise specified; FC, flow cytometry; FA, functional assay; Bisu, bisulfilte sequencing Supplemental Table 2: Genes differentially expressed in intratumoral PD-1intICOS-hi cells, compared to PD-1hiICOSint and PD 1-ICOS-. Supplemental Table 3: Markers and antibodies used for mass cytometry.
- Open Access
- 31 March 2023
- Published by American Association for Cancer Research (AACR)
Supplemental Figure legends from Regulatory T Cells in Ovarian Cancer Are Characterized by a Highly Activated Phenotype Distinct from that in Melanoma
Legends to supplemental figures 1-6
- 31 March 2023
- Published by American Association for Cancer Research (AACR)
Open AccessSupplemental Figure legends from Regulatory T Cells in Ovarian Cancer Are Characterized by a Highly Activated Phenotype Distinct from that in Melanoma
Legends to supplemental figures 1-6
- Open Access
- 31 March 2023
- Published by American Association for Cancer Research (AACR)
Figure S6 from Regulatory T Cells in Ovarian Cancer Are Characterized by a Highly Activated Phenotype Distinct from that in Melanoma
Analysis of PD-1 expression by CD8 T cells
- 31 March 2023
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S6 from Regulatory T Cells in Ovarian Cancer Are Characterized by a Highly Activated Phenotype Distinct from that in Melanoma
Analysis of PD-1 expression by CD8 T cells
- Open Access
- 31 March 2023
- Published by American Association for Cancer Research (AACR)
Figure S3 from Regulatory T Cells in Ovarian Cancer Are Characterized by a Highly Activated Phenotype Distinct from that in Melanoma
Analysis of CD27, CD28 and DNAM-1 expression by Treg cells
- 31 March 2023
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S3 from Regulatory T Cells in Ovarian Cancer Are Characterized by a Highly Activated Phenotype Distinct from that in Melanoma
Analysis of CD27, CD28 and DNAM-1 expression by Treg cells
- Open Access
- 31 March 2023
- Published by American Association for Cancer Research (AACR)
Figure S5 from Regulatory T Cells in Ovarian Cancer Are Characterized by a Highly Activated Phenotype Distinct from that in Melanoma
Analysis of Treg-hi and Treg-lo subpopulations by mass and flow cytometry
- 31 March 2023
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S5 from Regulatory T Cells in Ovarian Cancer Are Characterized by a Highly Activated Phenotype Distinct from that in Melanoma
Analysis of Treg-hi and Treg-lo subpopulations by mass and flow cytometry
- Open Access
- 31 March 2023
- Published by American Association for Cancer Research (AACR)
Figure S4 from Regulatory T Cells in Ovarian Cancer Are Characterized by a Highly Activated Phenotype Distinct from that in Melanoma
Gating strategy and bivariate analysis of mass cytometry data
- 31 March 2023
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S4 from Regulatory T Cells in Ovarian Cancer Are Characterized by a Highly Activated Phenotype Distinct from that in Melanoma
Gating strategy and bivariate analysis of mass cytometry data
- Open Access
- 31 March 2023
- Published by American Association for Cancer Research (AACR)
Figure S2 from Regulatory T Cells in Ovarian Cancer Are Characterized by a Highly Activated Phenotype Distinct from that in Melanoma
Global analyses of RNA-Seq data and expression of canonical Treg cell genes
- 31 March 2023
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S2 from Regulatory T Cells in Ovarian Cancer Are Characterized by a Highly Activated Phenotype Distinct from that in Melanoma
Global analyses of RNA-Seq data and expression of canonical Treg cell genes
- Open Access
- 31 March 2023
- Published by American Association for Cancer Research (AACR)
Supplemental Figure legends from Regulatory T Cells in Ovarian Cancer Are Characterized by a Highly Activated Phenotype Distinct from that in Melanoma
Legends to supplemental figures 1-6
- 31 March 2023
- Published by American Association for Cancer Research (AACR)
Open AccessSupplemental Figure legends from Regulatory T Cells in Ovarian Cancer Are Characterized by a Highly Activated Phenotype Distinct from that in Melanoma
Legends to supplemental figures 1-6
- Open Access
- 31 March 2023
- Published by American Association for Cancer Research (AACR)
Figure S1 from Regulatory T Cells in Ovarian Cancer Are Characterized by a Highly Activated Phenotype Distinct from that in Melanoma
Flow cytometry analysis of intratumoral Treg cells
- 31 March 2023
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S1 from Regulatory T Cells in Ovarian Cancer Are Characterized by a Highly Activated Phenotype Distinct from that in Melanoma
Flow cytometry analysis of intratumoral Treg cells